EP3310363A4 - Formulations antimicrobiennes - Google Patents

Formulations antimicrobiennes Download PDF

Info

Publication number
EP3310363A4
EP3310363A4 EP16812480.8A EP16812480A EP3310363A4 EP 3310363 A4 EP3310363 A4 EP 3310363A4 EP 16812480 A EP16812480 A EP 16812480A EP 3310363 A4 EP3310363 A4 EP 3310363A4
Authority
EP
European Patent Office
Prior art keywords
antimicrobial formulations
antimicrobial
formulations
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP16812480.8A
Other languages
German (de)
English (en)
Other versions
EP3310363A1 (fr
Inventor
Bahram Memarzadeh
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Common Pharma Inc
Original Assignee
Common Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Common Pharma Inc filed Critical Common Pharma Inc
Publication of EP3310363A1 publication Critical patent/EP3310363A1/fr
Publication of EP3310363A4 publication Critical patent/EP3310363A4/fr
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/22—Boron compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EP16812480.8A 2015-06-18 2016-06-17 Formulations antimicrobiennes Pending EP3310363A4 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201562181202P 2015-06-18 2015-06-18
PCT/US2016/037947 WO2016205574A1 (fr) 2015-06-18 2016-06-17 Formulations antimicrobiennes

Publications (2)

Publication Number Publication Date
EP3310363A1 EP3310363A1 (fr) 2018-04-25
EP3310363A4 true EP3310363A4 (fr) 2019-02-13

Family

ID=57546223

Family Applications (1)

Application Number Title Priority Date Filing Date
EP16812480.8A Pending EP3310363A4 (fr) 2015-06-18 2016-06-17 Formulations antimicrobiennes

Country Status (3)

Country Link
EP (1) EP3310363A4 (fr)
CN (1) CN108367026A (fr)
WO (1) WO2016205574A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112236163B (zh) * 2018-06-13 2024-07-02 京都生物制药株式会社 使用协同量的硼酸增强缩酚酸肽抗生素的抗菌作用
TR201903211A2 (tr) * 2019-03-04 2019-03-21 Kahramanmaras Suetcue Imam Ueniversitesi İçi̇lebi̇li̇r bor solüsyonu

Citations (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000024425A1 (fr) * 1998-10-27 2000-05-04 Alcon Laboratories, Inc. Systeme conservateur pour compositions pharmaceutiques a administration locale
WO2001019366A1 (fr) * 1999-09-13 2001-03-22 Insite Vision Incorporated Traitement topique utilise dans la prevention d'infections oculaires
CN1895219A (zh) * 2006-06-22 2007-01-17 武汉远大制药集团有限公司 一种苄达赖氨酸眼用凝胶制剂及其制备方法
CN1895218A (zh) * 2006-06-22 2007-01-17 武汉远大制药集团有限公司 一种吡诺克辛和其钠盐的眼用凝胶制剂及其制备方法
CN1961879A (zh) * 2005-11-09 2007-05-16 上海医药工业研究院 组成石杉碱甲鼻用原位凝胶喷雾剂的药物组合物、其制备方法及用途
CN1981858A (zh) * 2005-12-16 2007-06-20 杨伟荣 一种百草妇炎清凝胶及其制备方法
US20070298126A1 (en) * 2006-06-22 2007-12-27 Jack Howard Kessler Method for the eradication of pathogens including S. aureus and antibiotic resistant microbes from the upper respiratory tract of mammals and for inhibiting the activation of immune cells
US20110135743A1 (en) * 2009-12-03 2011-06-09 Alcon Research, Ltd. Carboxyvinyl polymer-containing nanoparticle suspensions
US20120070401A1 (en) * 2010-09-21 2012-03-22 Jinzhong Zhang Composition and Method for Promoting Wound Healing
EP2526923A1 (fr) * 2009-11-27 2012-11-28 Shenyang Xingqi Pharmaceutical Co., Ltd. Gel ophtalmique de gatifloxacine et procédé de préparation de celui-ci
US20130177599A1 (en) * 2012-01-06 2013-07-11 Insite Vision Incorporated Methods and kits for extending contact lens use
WO2014168592A1 (fr) * 2013-04-08 2014-10-16 Yeditepe Universitesi Combinaison de gel antiviral
WO2015070630A1 (fr) * 2013-11-18 2015-05-21 中国医学科学院生物医学工程研究所 Utilisation d'un nouveau type de préparation pharmaceutique anti-pvh

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5853767A (en) * 1997-01-02 1998-12-29 Melman; Steven A. Compositions for treating fungal, parasitic and/or bacterial infections, especially infections of organs such as the skin and vagina
EA010155B1 (ru) * 2002-12-18 2008-06-30 Феррер Интернасионал, С.А. Вагинальная мукоадгезивная композиция на основе нитрата сертаконазола, фармацевтический набор на основе композиции, фармацевтическая дозированная форма для лечения вульвовагинального кандидоза и способ его лечения
CA2839847C (fr) * 2003-06-13 2016-03-15 Masood A. Chowhan Compositions ophtalmologiques contenant une association synergique de deux polymeres
US7914803B2 (en) * 2003-06-13 2011-03-29 Alcon, Inc. Ophthalmic compositions containing a synergistic combination of three polymers
US8722123B2 (en) * 2008-05-22 2014-05-13 University Of Georgia Research Foundation, Inc. Antimicrobial composition and use as food treatment
US9248159B2 (en) * 2008-10-14 2016-02-02 Robert Stanley Berman MRSA bactericidal topical gel
EP2630952A1 (fr) * 2012-02-23 2013-08-28 Novagali Pharma S.A. Dispersions d'huile à conservation indépendante comprénant de l'acide borique
CN105362289B (zh) * 2015-10-24 2018-08-31 惠峪 一种阴道滞留硼酸制剂及其制备方法

Patent Citations (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000024425A1 (fr) * 1998-10-27 2000-05-04 Alcon Laboratories, Inc. Systeme conservateur pour compositions pharmaceutiques a administration locale
WO2001019366A1 (fr) * 1999-09-13 2001-03-22 Insite Vision Incorporated Traitement topique utilise dans la prevention d'infections oculaires
CN1961879A (zh) * 2005-11-09 2007-05-16 上海医药工业研究院 组成石杉碱甲鼻用原位凝胶喷雾剂的药物组合物、其制备方法及用途
CN1981858A (zh) * 2005-12-16 2007-06-20 杨伟荣 一种百草妇炎清凝胶及其制备方法
US20070298126A1 (en) * 2006-06-22 2007-12-27 Jack Howard Kessler Method for the eradication of pathogens including S. aureus and antibiotic resistant microbes from the upper respiratory tract of mammals and for inhibiting the activation of immune cells
CN1895218A (zh) * 2006-06-22 2007-01-17 武汉远大制药集团有限公司 一种吡诺克辛和其钠盐的眼用凝胶制剂及其制备方法
CN1895219A (zh) * 2006-06-22 2007-01-17 武汉远大制药集团有限公司 一种苄达赖氨酸眼用凝胶制剂及其制备方法
EP2526923A1 (fr) * 2009-11-27 2012-11-28 Shenyang Xingqi Pharmaceutical Co., Ltd. Gel ophtalmique de gatifloxacine et procédé de préparation de celui-ci
US20110135743A1 (en) * 2009-12-03 2011-06-09 Alcon Research, Ltd. Carboxyvinyl polymer-containing nanoparticle suspensions
US20120070401A1 (en) * 2010-09-21 2012-03-22 Jinzhong Zhang Composition and Method for Promoting Wound Healing
US20130177599A1 (en) * 2012-01-06 2013-07-11 Insite Vision Incorporated Methods and kits for extending contact lens use
WO2014168592A1 (fr) * 2013-04-08 2014-10-16 Yeditepe Universitesi Combinaison de gel antiviral
WO2015070630A1 (fr) * 2013-11-18 2015-05-21 中国医学科学院生物医学工程研究所 Utilisation d'un nouveau type de préparation pharmaceutique anti-pvh

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO2016205574A1 *

Also Published As

Publication number Publication date
EP3310363A1 (fr) 2018-04-25
WO2016205574A1 (fr) 2016-12-22
CN108367026A (zh) 2018-08-03

Similar Documents

Publication Publication Date Title
IL268697A (en) Formulations
DK3688162T3 (da) Formuleringer
EP3337502A4 (fr) Formulation anti-ifnar1 stable
EP3291824A4 (fr) Thérapie antimicrobienne
MA50657A (fr) Formulations de niraparib
LT3240416T (lt) Fungicidinės kompozicijos
EP3236978C0 (fr) Composition antimicrobienne
PL4070788T3 (pl) Formulacje farmaceutyczne
BR112017001922A2 (pt) composições fungicidas
EP3415008A4 (fr) Composition germicide
DK3250182T3 (da) Dispergible sammensætninger
DK3334726T3 (da) Plinabulinsammensætninger
EP3364945C0 (fr) Formulation solide
EP3500102C0 (fr) Composition antimicrobienne
BR112017014838A2 (pt) benzoxaboróis microbicidas
EP3443078A4 (fr) Compositions antimicrobiennes
EP3383912A4 (fr) Formulations topiques
EP3458041A4 (fr) Compositions antibactériennes
DK3451829T3 (da) Antimikrobielle sammensætninger
EP3397289C0 (fr) Lingette antimicrobienne
FR3020948B1 (fr) Composition antimicrobienne
HUE063178T2 (hu) Kopanlizib formulációi
DK3316857T3 (da) Multifasiske sammensætninger
DK3280447T3 (da) Farmaceutiske formuleringer
IL272167A (en) Hemopexin formulations

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20180111

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20190116

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 9/107 20060101ALI20190109BHEP

Ipc: A61K 9/06 20060101ALI20190109BHEP

Ipc: A61K 47/32 20060101ALI20190109BHEP

Ipc: A61K 9/08 20060101AFI20190109BHEP

Ipc: A61K 33/22 20060101ALI20190109BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

17Q First examination report despatched

Effective date: 20210309

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN